🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label randomized single dose two-way crossover study to com...
Status
Completed
Location
MDS Pharma Services
Start Date
2007-07
Trial ID
NCT00806078
Treatments Being Tested
Ciprofloxacin is moderate inhibitor of cytochrome P450 1A2 (CYP1A2), one of...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00785980
Treatments Being Tested
The purpose of this study is to evaluate and compare the relative bioavaila...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00726414
Treatments Being Tested
Rosiglitazone is predominantly metabolized by cytochrome P450 (CYP) 2C8. Qu...
Status
Completed
Location
Cetero Research
Start Date
2008-09
Trial ID
NCT00785213
Treatments Being Tested
The purpose of this study is to evaluate and compare the dose proportionali...
Status
Completed
Location
Multiple Locations
Start Date
2004-05
Trial ID
NCT00726895
Treatments Being Tested
This is an open label non-randomized single sequence, single group two way ...
Status
Completed
Location
MDS Pharma Services
Start Date
2007-03
Trial ID
NCT00785486
Treatments Being Tested
In a prior in vitro study using human hepatocytes quinine was shown to indu...
Status
Completed
Location
PRACS Institute
Start Date
2007-08
Trial ID
NCT00779259
Treatments Being Tested
The purpose of this study is to evaluate and compare the relative bioavaila...
Status
Completed
Location
PRACS
Start Date
2004-02
Trial ID
NCT00727272